Drug persistence and need for dose intensification to adalimumab therapy; the importance of therapeutic drug monitoring in inflammatory bowel diseases

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1471-230X

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Drug persistence and need for dose intensification to adalimumab therapy; the importance of therapeutic drug monitoring in inflammatory bowel diseases ; volume:17 ; number:1 ; day:8 ; month:8 ; year:2017 ; pages:1-7 ; date:12.2017
BMC gastroenterology ; 17, Heft 1 (8.8.2017), 1-7, 12.2017

Creator: Gonczi, Lorant

Contributor: Kurti, Zsuzsanna
Rutka, Mariann
Vegh, Zsuzsanna
Farkas, Klaudia
Lovasz, Barbara D.
Golovics, Petra A.
Gecse, Krisztina B.
Szalay, Balazs
Molnar, Tamas
Lakatos, Péter L.
SpringerLink (Online service)

DOI: 10.1186/s12876-017-0654-1

URN: urn:nbn:de:1111-20171026166

Rights: Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:24 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Gonczi, Lorant
Kurti, Zsuzsanna
Rutka, Mariann
Vegh, Zsuzsanna
Farkas, Klaudia
Lovasz, Barbara D.
Golovics, Petra A.
Gecse, Krisztina B.
Szalay, Balazs
Molnar, Tamas
Lakatos, Péter L.
SpringerLink (Online service)

Other Objects (12)

Adalimumab and anti-adalimumab LISA-TRACKER immunoassays performance criteria for therapeutic drug monitoring of adalimumab-amgen biosimilar (ABP501)

Drug-induced small-bowel mucosal atrophy

Therapeutic Drug Monitoring in Inflammatory Bowel Disease

Non-persistence to antihypertensive drug therapy in Lithuania

Lipid-lowering drugs and inflammatory bowel disease’s risk: a drug-target Mendelian randomization study

Impact of gastric and bowel surgery on gastrointestinal drug delivery

Pathways to the persistence of drug use despite its adverse consequences

Complex genetic encoding of the hepatitis B virus on-drug persistence

Efficacy and safety of infliximab and adalimumab in inflammatory bowel disease patients

Zeitschrift

Drugs : evaluations of drugs and drug therapy

Cost-Effectiveness of Therapeutic Drug Monitoring-Guided Adalimumab Therapy in Rheumatic Diseases: A Prospective, Pragmatic Trial

Drug Persistence of Biologic Treatments in Psoriasis: A Swedish National Population Study

Adalimumab and anti-adalimumab LISA-TRACKER immunoassays performance criteria for therapeutic drug monitoring of adalimumab-amgen biosimilar (ABP501)

Drug-induced small-bowel mucosal atrophy

Therapeutic Drug Monitoring in Inflammatory Bowel Disease

Non-persistence to antihypertensive drug therapy in Lithuania

Lipid-lowering drugs and inflammatory bowel disease’s risk: a drug-target Mendelian randomization study

Impact of gastric and bowel surgery on gastrointestinal drug delivery

Pathways to the persistence of drug use despite its adverse consequences

Complex genetic encoding of the hepatitis B virus on-drug persistence

Efficacy and safety of infliximab and adalimumab in inflammatory bowel disease patients

Zeitschrift

Drugs : evaluations of drugs and drug therapy

Cost-Effectiveness of Therapeutic Drug Monitoring-Guided Adalimumab Therapy in Rheumatic Diseases: A Prospective, Pragmatic Trial

Drug Persistence of Biologic Treatments in Psoriasis: A Swedish National Population Study

Adalimumab and anti-adalimumab LISA-TRACKER immunoassays performance criteria for therapeutic drug monitoring of adalimumab-amgen biosimilar (ABP501)

Drug-induced small-bowel mucosal atrophy

Therapeutic Drug Monitoring in Inflammatory Bowel Disease

Non-persistence to antihypertensive drug therapy in Lithuania

Lipid-lowering drugs and inflammatory bowel disease’s risk: a drug-target Mendelian randomization study

Impact of gastric and bowel surgery on gastrointestinal drug delivery

Pathways to the persistence of drug use despite its adverse consequences

Complex genetic encoding of the hepatitis B virus on-drug persistence

Efficacy and safety of infliximab and adalimumab in inflammatory bowel disease patients

Zeitschrift

Drugs : evaluations of drugs and drug therapy

Cost-Effectiveness of Therapeutic Drug Monitoring-Guided Adalimumab Therapy in Rheumatic Diseases: A Prospective, Pragmatic Trial

Drug Persistence of Biologic Treatments in Psoriasis: A Swedish National Population Study

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Drug persistence and need for dose intensification to adalimumab therapy; the importance of therapeutic drug monitoring in inflammatory bowel diseases

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Adalimumab and anti-adalimumab LISA-TRACKER immunoassays performance criteria for therapeutic drug monitoring of adalimumab-amgen biosimilar (ABP501)

Drug-induced small-bowel mucosal atrophy

Therapeutic Drug Monitoring in Inflammatory Bowel Disease

Non-persistence to antihypertensive drug therapy in Lithuania

Lipid-lowering drugs and inflammatory bowel disease’s risk: a drug-target Mendelian randomization study

Impact of gastric and bowel surgery on gastrointestinal drug delivery

Pathways to the persistence of drug use despite its adverse consequences

Complex genetic encoding of the hepatitis B virus on-drug persistence

Efficacy and safety of infliximab and adalimumab in inflammatory bowel disease patients

Drugs : evaluations of drugs and drug therapy

Cost-Effectiveness of Therapeutic Drug Monitoring-Guided Adalimumab Therapy in Rheumatic Diseases: A Prospective, Pragmatic Trial

Drug Persistence of Biologic Treatments in Psoriasis: A Swedish National Population Study

Adalimumab and anti-adalimumab LISA-TRACKER immunoassays performance criteria for therapeutic drug monitoring of adalimumab-amgen biosimilar (ABP501)

Drug-induced small-bowel mucosal atrophy

Therapeutic Drug Monitoring in Inflammatory Bowel Disease

Non-persistence to antihypertensive drug therapy in Lithuania

Lipid-lowering drugs and inflammatory bowel disease’s risk: a drug-target Mendelian randomization study

Impact of gastric and bowel surgery on gastrointestinal drug delivery

Pathways to the persistence of drug use despite its adverse consequences

Complex genetic encoding of the hepatitis B virus on-drug persistence

Efficacy and safety of infliximab and adalimumab in inflammatory bowel disease patients

Drugs : evaluations of drugs and drug therapy

Cost-Effectiveness of Therapeutic Drug Monitoring-Guided Adalimumab Therapy in Rheumatic Diseases: A Prospective, Pragmatic Trial

Drug Persistence of Biologic Treatments in Psoriasis: A Swedish National Population Study

Adalimumab and anti-adalimumab LISA-TRACKER immunoassays performance criteria for therapeutic drug monitoring of adalimumab-amgen biosimilar (ABP501)

Drug-induced small-bowel mucosal atrophy

Therapeutic Drug Monitoring in Inflammatory Bowel Disease

Non-persistence to antihypertensive drug therapy in Lithuania

Lipid-lowering drugs and inflammatory bowel disease’s risk: a drug-target Mendelian randomization study

Impact of gastric and bowel surgery on gastrointestinal drug delivery

Pathways to the persistence of drug use despite its adverse consequences

Complex genetic encoding of the hepatitis B virus on-drug persistence

Efficacy and safety of infliximab and adalimumab in inflammatory bowel disease patients

Drugs : evaluations of drugs and drug therapy

Cost-Effectiveness of Therapeutic Drug Monitoring-Guided Adalimumab Therapy in Rheumatic Diseases: A Prospective, Pragmatic Trial

Drug Persistence of Biologic Treatments in Psoriasis: A Swedish National Population Study

Related objects

Reset password